BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akiyama M, Ohtsuki S, Berry GJ, Liang DH, Goronzy JJ, Weyand CM. Innate and Adaptive Immunity in Giant Cell Arteritis. Front Immunol 2020;11:621098. [PMID: 33717054 DOI: 10.3389/fimmu.2020.621098] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Stamatis P, Turesson C, Michailidou D, Mohammad AJ. Pathogenesis of giant cell arteritis with focus on cellular populations. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1058600] [Reference Citation Analysis]
2 Higashida-Konishi M, Akiyama M, Shimada T, Hama S, Oshige T, Izumi K, Oshima H, Okano Y. Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy. Rheumatol Int 2022. [PMID: 36152056 DOI: 10.1007/s00296-022-05217-x] [Reference Citation Analysis]
3 Stock AT, Parsons S, Sharma VJ, James F, Starkey G, D'Costa R, Gordon CL, Wicks IP. Intimal macrophages develop from circulating monocytes during vasculitis. Clin Transl Immunology 2022;11:e1412. [PMID: 35991774 DOI: 10.1002/cti2.1412] [Reference Citation Analysis]
4 Parreau S, Liozon E, Chen JJ, Curumthaullee MF, Fauchais AL, Warrington K, Ly KH, Weyand CM. TEMPORAL ARTERY BIOPSY: A TECHNICAL GUIDE AND REVIEW OF ITS IMPORTANCE & INDICATIONS. Surv Ophthalmol 2022:S0039-6257(22)00120-5. [PMID: 35995251 DOI: 10.1016/j.survophthal.2022.08.008] [Reference Citation Analysis]
5 Rizzo C, La Barbera L, Miceli G, Tuttolomondo A, Guggino G. The innate face of Giant Cell Arteritis: Insight into cellular and molecular innate immunity pathways to unravel new possible biomarkers of disease. Front Mol Med 2022;2. [DOI: 10.3389/fmmed.2022.933161] [Reference Citation Analysis]
6 Yun T, Hua J, Ye W, Ni Z, Chen L, Zhu Y, Zhang C. Intergrated Transcriptomic and Proteomic Analysis Revealed the Differential Responses to Novel Duck Reovirus Infection in the Bursa of Fabricius of Cairna moschata. Viruses 2022;14:1615. [PMID: 35893682 DOI: 10.3390/v14081615] [Reference Citation Analysis]
7 van der Geest KSM, Sandovici M, Nienhuis PH, Slart RHJA, Heeringa P, Brouwer E, Jiemy WF. Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica. Front Med 2022;9:902155. [DOI: 10.3389/fmed.2022.902155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Jiang W, Sun M, Wang Y, Zheng M, Yuan Z, Mai S, Zhang X, Tang L, Liu X, Wang C, Wen Z. Critical Role of Notch-1 in Mechanistic Target of Rapamycin Hyperactivity and Vascular Inflammation in Patients With Takayasu Arteritis. Arthritis Rheumatol 2022. [PMID: 35212196 DOI: 10.1002/art.42103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Watts RA, Hatemi G, Burns JC, Mohammad AJ. Global epidemiology of vasculitis. Nat Rev Rheumatol 2022;18:22-34. [PMID: 34853411 DOI: 10.1038/s41584-021-00718-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 24.0] [Reference Citation Analysis]
10 Solimando AG, Vacca A, Dammacco F. Highlights in clinical medicine-Giant cell arteritis, polymyalgia rheumatica and Takayasu's arteritis: pathogenic links and therapeutic implications. Clin Exp Med 2021. [PMID: 34741677 DOI: 10.1007/s10238-021-00770-4] [Reference Citation Analysis]